Meloxicam for Headaches: Not Indicated—Better Alternatives Exist

Meloxicam is not a first-line treatment for headaches. It is an NSAID (COX-2 preferential) approved for osteoarthritis, rheumatoid arthritis, juvenile RA, and ankylosing spondylitis.

Why It’s Not Preferred for Headache

• No FDA indication for migraine, tension-type, or cluster headache.
• Slower onset (peak 5–6 hrs) vs. acute migraine agents (triptans, NSAIDs like ibuprofen/naproxen).
• Long half-life (20 hrs) → accumulation, GI/CV/renal risk with frequent use.
• Medication-overuse headache (MOH) risk if used >10–15 days/month.

Appropriate Headache Treatments

• Acute migraine: Triptans, gepants (ubrogepant, rimegepant), ditans (lasmiditan), NSAIDs (ibuprofen, naproxen), combination analgesics.
• Tension-type: Acetaminophen, NSAIDs, stress management.
• Preventive (if frequent): Beta-blockers, topiramate, amitriptyline, CGRP mAbs, onabotulinumtoxinA (chronic migraine).

If you’re taking meloxicam for arthritis and have headaches, discuss with your doctor—don’t self-medicate. The headache may need a separate, targeted plan.